W
REGN icon

Wealthfront’s Regeneron Pharmaceuticals REGN Stock Holding History

Wealthfront’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$236K Buy
+584
New +$222K ﹤0.01% 483
2018
Q2 		– Sell
-829
Closed -$285K – 518
2018
Q1 		$285K Sell
829
-213
-20% -$74.1K ﹤0.01% 443
2017
Q4 		$392K Sell
1,042
-551
-35% -$223K ﹤0.01% 396
2017
Q3 		$712K Sell
1,593
-222
-12% -$106K 0.01% 262
2017
Q2 		$891K Buy
1,815
+322
+22% +$141K 0.01% 169
2017
Q1 		$579K Buy
1,493
+289
+24% +$107K 0.01% 201
2016
Q4 		$442K Buy
1,204
+3
+0.2% +$1.14K 0.01% 219
2016
Q3 		$483K Buy
1,201
+614
+105% +$246K 0.01% 184
2016
Q2 		$205K Sell
587
-23
-4% -$8.86K 0.01% 338
2016
Q1 		$220K Sell
610
-416
-41% -$171K 0.01% 297
2015
Q4 		$557K Buy
1,026
+94
+10% +$50.9K 0.02% 132
2015
Q3 		$434K Buy
932
+103
+12% +$55.3K 0.02% 151
2015
Q2 		$423K Buy
829
+161
+24% +$78.6K 0.02% 133
2015
Q1 		$302K Buy
668
+168
+34% +$71.2K 0.01% 157
2014
Q4 		$205K Buy
500
+105
+27% +$41.3K 0.01% 210
2014
Q3 		$142K Buy
395
+250
+172% +$83.8K 0.01% 218
2014
Q2 		$45K Sell
145
-140
-49% -$41.5K ﹤0.01% 385
2014
Q1 		$87K Buy
+285
New +$87.8K 0.01% 153

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wealthfront's REGN Position: Q3 2018 in Review

Wealthfront opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2018: 584 shares worth $236K. The stake represents ﹤0.01% of the portfolio and ranks #483 among its holdings. This is a return to the name: Wealthfront previously reported a position in REGN as recently as Q1 2018.

Wealthfront first reported a position in REGN in Q1 2014 and has held it in 18 quarters since. The position peaked at $891K in Q2 2017. 645 funds tracked by Wall St. Rank hold REGN as of Q3 2018.

  • Wealthfront held 584 shares of Regeneron Pharmaceuticals worth $236K as of Q3 2018.
  • Regeneron Pharmaceuticals was a new Wealthfront position in Q3 2018.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Wealthfront's portfolio in Q3 2018, its #483 holding.
  • Wealthfront first reported a position in Regeneron Pharmaceuticals in Q1 2014 and has held it in 18 quarters since.
  • Wealthfront's Regeneron Pharmaceuticals position peaked at $891K in Q2 2017.
  • 645 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2018.

Based on Wealthfront's 13F filing for Q3 2018, filed 13 Nov 2018.